ICN Pharmaceuticals Inc.: An accounting firm has...
- Share via
ICN Pharmaceuticals Inc.: An accounting firm has confirmed that the company garnered 94% of the shares voted after its 10-month battle against dissident stockbroker Rafi M. Khan for control of the drug manufacturer. Each of the Costa Mesa company’s 10 directors received more than 11.3 million of the shares voted. Kahn and his slate of replacement directors received 728,000 shares. ICN has 12 million shares outstanding.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
